Quorum Health (NYSE: QHC) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it compare to its rivals? We will compare Quorum Health to related businesses based on the strength of its dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership.
This table compares Quorum Health and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Quorum Health Competitors||3.52%||3.52%||4.31%|
81.7% of Quorum Health shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 4.7% of Quorum Health shares are held by company insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation & Earnings
This table compares Quorum Health and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Quorum Health||$2.42 billion||-$347.68 million||-0.70|
|Quorum Health Competitors||$1.06 billion||-$22.56 million||753.32|
Quorum Health has higher revenue, but lower earnings than its rivals. Quorum Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Quorum Health has a beta of 7.53, indicating that its stock price is 653% more volatile than the S&P 500. Comparatively, Quorum Health’s rivals have a beta of 1.47, indicating that their average stock price is 47% more volatile than the S&P 500.
This is a breakdown of recent ratings and recommmendations for Quorum Health and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Quorum Health Competitors||58||326||511||9||2.52|
Quorum Health presently has a consensus price target of $3.88, indicating a potential downside of 11.53%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 21.38%. Given Quorum Health’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Quorum Health has less favorable growth aspects than its rivals.
Quorum Health rivals beat Quorum Health on 9 of the 12 factors compared.
Quorum Health Company Profile
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery and rehabilitation services.
What are top analysts saying about Quorum Health Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Quorum Health Corp and related companies.